Hemolytic anemia: Difference between revisions
(Added table for lab interpretation) |
|||
| (19 intermediate revisions by 6 users not shown) | |||
| Line 1: | Line 1: | ||
== | ==Background== | ||
*Wide variety of clinical presentation given the large differential diagnosis | *Wide variety of clinical presentation given the large differential diagnosis | ||
* | *Clinical presentation and lab findings differ depending on intravascular vs. extravascular hemolysis, acute vs. chronic | ||
*Common | *Common findings | ||
**low hemoglobin and hematocrit | |||
**reticulocytosis | |||
**elevated indirect bilirubin | |||
*Most important lab to elucidate diagnosis is blood smear | *Most important lab to elucidate diagnosis is blood smear | ||
*Most common emergent presentations are due to acute intravascular hemolytic anemias | *Most common emergent presentations are due to acute intravascular hemolytic anemias | ||
===Etiologies=== | |||
''Divided by etiology: acquired vs. hereditary'' | |||
*Acquired: | |||
**Microangiopathic ([[MAHA]]), [[Autoimmune hemolytic anemia|autoimmune]], infection | |||
*Hereditary: | |||
**[[Sickle cell disease]], [[thalassemia]], [[G6PD]], [[hereditary spherocytosis]] | |||
==Clinical Features== | ==Clinical Features== | ||
===History=== | ===History=== | ||
*Anemia symptoms | *[[Anemia]] symptoms | ||
**Dyspnea | **[[Dyspnea]]/dypsnea on exertion | ||
**Fatigue | **Fatigue | ||
*Stigmata of intravascular hemolysis | *Stigmata of intravascular hemolysis | ||
**Jaundice (new onset) | **[[Jaundice]] (new onset) | ||
**Dark urine | **Dark urine | ||
**Changes in stool color | **Changes in stool color | ||
** Neuro (TTP) | **Neuro ([[TTP]]) | ||
*** Headache | ***[[Headache]] | ||
*** | ***[[Altered mental status]] | ||
*** Seizure | ***[[Seizure]] | ||
*** Focal | ***[[Focal neuro deficits]] | ||
*** Coma | ***[[Coma]] | ||
** Rectal | **[[Rectal bleeding]] ([[HUS]]) | ||
*Stigmata of thrombocytopenia | *Stigmata of [[thrombocytopenia]] | ||
**Petechiae | **[[Petechiae]] | ||
**Bleeding | **Bleeding | ||
*Stigmata of extravascular RBC destruction | *Stigmata of extravascular RBC destruction | ||
**Abdominal pain | **[[Abdominal pain]] | ||
**Back pain | **[[Back pain]] | ||
*Systemic Symptoms | *Systemic Symptoms | ||
** | **[[Fever]] | ||
**Night sweats | **Night sweats | ||
**Weight loss | **Weight loss | ||
| Line 43: | Line 47: | ||
**Initiation of new medication | **Initiation of new medication | ||
**Recent travel | **Recent travel | ||
**Recent | **Recent [[insect bites]] | ||
===PMH=== | ===PMH=== | ||
*Hereditary | *[[Hereditary spherocytosis]] | ||
*Sickle | *[[Sickle cell disease]] | ||
*G6PD Deficiency recently started new medication: | *[[G6PD]] Deficiency recently started new medication: | ||
** Dapsone | **[[Dapsone]] | ||
**Phenazopyridine | **Phenazopyridine | ||
**Nitrofurantoin | **[[Nitrofurantoin]] | ||
**Primaquine | **Primaquine | ||
**Rasburicase | **[[Rasburicase]] | ||
**Methylene blue | **[[Methylene blue]] | ||
**Tolonium chloride (toluidine blue) | **Tolonium chloride (toluidine blue) | ||
*Malignancy | *Malignancy | ||
*Renal | *[[Renal failure]] | ||
*Connective | *[[Connective tissue disease]] | ||
* Family history of Anemia/Bleeding | *Family history of Anemia/Bleeding | ||
===Physical Exam=== | ===Physical Exam=== | ||
*Cardiovascular | *Cardiovascular | ||
**Tachycardia with flow murmur | **[[Tachycardia]] with flow murmur | ||
** Heart murmur – prosthetic heart valve | **Heart murmur – prosthetic heart valve | ||
*Abdominal Exam | *Abdominal Exam | ||
** Hepatomegaly | **Hepatomegaly, splenomegaly | ||
** | **[[Ascites]] | ||
*Skin | *Skin | ||
**Petechiae | **[[Petechiae]] | ||
**Bruising | **Bruising | ||
**Lymphadenopathy | **[[Lymphadenopathy]] | ||
**Brown recluse spider bites | **[[Brown recluse]] spider bites | ||
==Differential Diagnosis== | ==Differential Diagnosis== | ||
===Acquired Hemolytic Anemia=== | ===Acquired Hemolytic Anemia=== | ||
====Microangiopathic Hemolytic Anemia==== | ====Microangiopathic Hemolytic Anemia==== | ||
*HUS | *[[HUS]] | ||
*TTP | *[[TTP]] | ||
*DIC | *[[DIC]] | ||
* | *[[Hypertensive emergency]] | ||
====Autoimmune==== | ====Autoimmune==== | ||
* | *[[Autoimmune hemolytic anemia]] | ||
====Infection==== | ====Infection==== | ||
*Malaria | *[[Malaria]] | ||
* | *[[Babesiosis]] | ||
====Other==== | ====Other==== | ||
*Brown recluse spider venom | *[[Brown recluse spider venom]] | ||
===Hereditary/Congenital Hemolytic Anemia=== | ===Hereditary/Congenital Hemolytic Anemia=== | ||
*G6PD – medication induced hemolytic anemia | *[[G6PD]] – medication induced hemolytic anemia | ||
*Sickle | *[[Sickle cell disease]] | ||
*Thalassemia | *[[Thalassemia]] | ||
*Hereditary | *[[Hereditary spherocytosis]] | ||
==Evaluation== | ==Evaluation== | ||
===Workup=== | |||
*CBC | |||
** | **Low hemaglobin/hematocrit | ||
**Low platelet count → microangiopathic hemolytic anemia | |||
*Blood smear | |||
*Reticulocyte count | |||
*CMP | |||
**Most important: indirect bilirubin and creatinine | |||
* | *[[UA]] (for hemoglobin, hemosiderin), uHCG | ||
*PT/INR | |||
*Hemolysis labs | |||
**LDH | |||
**Haptoglobin | |||
**Fibrinogen | |||
*Direct Anti-Globulin Test or Coombs test | |||
*If concern for Malaria: | |||
**Thick and thin prep | |||
**Parasitemia | |||
*HIV | |||
*Blood cultures, urine cultures | |||
*Consider [[LP]] if neuro symptoms | |||
==Lab Interpretation== | ===Lab Interpretation=== | ||
{| {{table}} | {| {{table}} | ||
| align="center" style="background:#f0f0f0;"|'''Microangiopathic Hemolytic Anemia''' | | align="center" style="background:#f0f0f0;"|'''Microangiopathic Hemolytic Anemia''' | ||
| Line 135: | Line 137: | ||
| align="center" style="background:#f0f0f0;"|'''Thick/Thin Prep''' | | align="center" style="background:#f0f0f0;"|'''Thick/Thin Prep''' | ||
|- | |- | ||
| HUS||low||low||elevated||highly elevated||schistocytes||wnl||elevated||low||wnl||negative||negative | | [[HUS]]||low||low||elevated||highly elevated||schistocytes||wnl||elevated||low||wnl||negative||negative | ||
|- | |- | ||
| TTP||low||low||elevated||elevated||schistocytes||wnl||elevated||low||wnl||negative||negative | | [[TTP]]||low||low||elevated||elevated||schistocytes||wnl||elevated||low||wnl||negative||negative | ||
|- | |- | ||
| DIC||low||low||elevated||elevated||schistocytes|| | | [[DIC]]||low||low||elevated||elevated||schistocytes||elevated||elevated||low||low||negative||negative | ||
|- | |- | ||
| Malignant Hypertension||low||low||elevated||variable||schistocytes||||elevated||low||||negative||negative | | Malignant Hypertension||low||low||elevated||variable||schistocytes||||elevated||low||||negative||negative | ||
| Line 171: | Line 173: | ||
| align="center" style="background:#f0f0f0;"|'''Thick/Thin Prep''' | | align="center" style="background:#f0f0f0;"|'''Thick/Thin Prep''' | ||
|- | |- | ||
| Malaria||low||wnl||elevated||||see thick/thin prep||variable||elevated||low||wnl||negative||paracytes | | [[Malaria]]||low||wnl||elevated||||see thick/thin prep||variable||elevated||low||wnl||negative||paracytes | ||
|- | |- | ||
| Babesia||||||||||see thick/thin prep||||||||||negative||paracytes | | Babesia||||||||||see thick/thin prep||||||||||negative||paracytes | ||
| Line 188: | Line 190: | ||
| align="center" style="background:#f0f0f0;"|'''Thick/Thin Prep''' | | align="center" style="background:#f0f0f0;"|'''Thick/Thin Prep''' | ||
|- | |- | ||
| Brown | | [[Brown recluse]]||low||wnl||elevated||||||||elevated||||||positive||negative | ||
|} | |} | ||
==Management == | |||
*ABC’s and | ==Management== | ||
*ABC’s and resuscitation if necessary, 2 large bore IVs | |||
*Emergent hematology consultation if patient is very ill appearing | *Emergent hematology consultation if patient is very ill appearing | ||
===Acquired Hemolytic Anemia=== | ===Acquired Hemolytic Anemia=== | ||
====Microangiopathic Hemolytic Anemia==== | ====Microangiopathic Hemolytic Anemia==== | ||
*HUS | *[[HUS]] | ||
**Supportive Care | **Supportive Care | ||
***Hydration | ***Hydration | ||
***Pain control | ***Pain control | ||
**Hemodialysis if acute renal failure | **Hemodialysis if acute renal failure | ||
**Do NOT give | **Do NOT give antibiotics: results in increased expression of Shiga Toxin from E. Coli O157:H7 | ||
*[[TTP]] | |||
*TTP | **'''Avoid''' platelet transfusion, except in life-threatening bleeding or intracranial hemorrhage | ||
** Avoid platelet transfusion, except in life-threatening bleeding or intracranial hemorrhage | **[[Plasma exchange]] | ||
**Plasma | **If Plasma exchange cannot be performed immediately, give FFP and plasmapharese later. | ||
** If Plasma exchange cannot be performed immediately, give FFP and | **Factor VIII concentrate | ||
** | *[[DIC]] | ||
**Platelet transfusion if count is <50,000 and/or significant bleeding | |||
*DIC | |||
** | |||
**pRBC if active bleeding or hemodynamically unstable | **pRBC if active bleeding or hemodynamically unstable | ||
**FFP if active bleeding | **[[FFP]] if active bleeding | ||
**Cryoprecipitate if fibrinogen <150 and bleeding | **[[Cryoprecipitate]] if fibrinogen <150 and bleeding | ||
**TXA is only indicated for active or massive bleeding | **[[TXA]] is only indicated for active or massive bleeding | ||
*[[Malignant hypertension]] | |||
*Malignant hypertension | **Reduce blood pressure as clinically indicated | ||
** | |||
====Autoimmune==== | ====Autoimmune==== | ||
*Warm | *Warm antibody autoimmune hemolytic anemia | ||
**High-dose corticosteroids PO (1-2mg/kg per day for 3-4 weeks) | **High-dose [[corticosteroids]] PO (1-2mg/kg per day for 3-4 weeks) | ||
** Monoclonal antibodies and immunosuppressive agents | **Monoclonal antibodies and immunosuppressive agents | ||
** Plasma exchange for severe hemolysis | **Plasma exchange for severe hemolysis | ||
** Allogeneic RBC transfusion for life-threatening anemia | **Allogeneic RBC transfusion for life-threatening anemia | ||
====Infection==== | ====Infection==== | ||
*Malaria | *[[Malaria]] | ||
** Visit CDC website to determine resistance pattern: https://www.cdc.gov/malaria/diagnosis_treatment/treatment.html | **Visit CDC website to determine resistance pattern: https://www.cdc.gov/malaria/diagnosis_treatment/treatment.html | ||
** CDC Malaria Hotline: (770) 488-7788 or (855) 856-4713 toll-free Monday-Friday 9 am to 5 pm EST - (770) 488-7100 after hours, weekends and holidays | **CDC Malaria Hotline: (770) 488-7788 or (855) 856-4713 toll-free Monday-Friday 9 am to 5 pm EST - (770) 488-7100 after hours, weekends and holidays | ||
*[[Babesiosis]] | |||
* | |||
**Mild/moderate Disease | **Mild/moderate Disease | ||
*** Atovaquone 750mg PO q12hr | ***[[Atovaquone]] 750mg PO q12hr '''AND''' | ||
***[[Azithromycin]] 500mg PO on day 1, then 250mg/day PO | |||
**Severe Disease | **Severe Disease | ||
*** | ***[[Clindamycin]] 300-600mg IV QID '''OR''' 600mg PO TID '''AND''' | ||
***[[Quinine]] 650mg PO TID x7-10 days | |||
***Consider exchange transfusion if parasitemia >10% | ***Consider exchange transfusion if parasitemia >10% | ||
**Supportive treatment | **Supportive treatment | ||
====Other==== | ====Other==== | ||
*Brown recluse spider | *[[Brown recluse spider bite]] | ||
**Supportive care | **Supportive care | ||
***Hemodynamic support with fluids and pressers if necessary | ***Hemodynamic support with fluids and pressers if necessary | ||
| Line 246: | Line 246: | ||
===Hereditary/Congenital Hemolytic Anemia=== | ===Hereditary/Congenital Hemolytic Anemia=== | ||
*G6PD | *[[G6PD]] | ||
**Stop new medications | **Stop new medications | ||
**Treat any infections aggressively | **Treat any infections aggressively | ||
**Ovoid oxidant drugs | **Ovoid oxidant drugs | ||
**Blood transfusion if severe illness | **Blood transfusion if severe illness | ||
*[[Sickle Cell Disease]], [[Thalassemia]], [[Hereditary spherocytosis]] | |||
*Sickle Cell Disease | **Hemolytic anemia in the above diseases typically chronic, usually does not require treatment in ED | ||
**Hemolytic anemia | |||
==Disposition== | ==Disposition== | ||
*Depends on severity, complications, etc. | |||
==Also | ==See Also== | ||
*[[Anemia]] | |||
==External Links== | ==External Links== | ||
==References== | ==References== | ||
<references/> | |||
[[Category:Heme/Onc]] | |||
Latest revision as of 03:09, 14 December 2020
Background
- Wide variety of clinical presentation given the large differential diagnosis
- Clinical presentation and lab findings differ depending on intravascular vs. extravascular hemolysis, acute vs. chronic
- Common findings
- low hemoglobin and hematocrit
- reticulocytosis
- elevated indirect bilirubin
- Most important lab to elucidate diagnosis is blood smear
- Most common emergent presentations are due to acute intravascular hemolytic anemias
Etiologies
Divided by etiology: acquired vs. hereditary
- Acquired:
- Microangiopathic (MAHA), autoimmune, infection
- Hereditary:
Clinical Features
History
- Anemia symptoms
- Dyspnea/dypsnea on exertion
- Fatigue
- Stigmata of intravascular hemolysis
- Jaundice (new onset)
- Dark urine
- Changes in stool color
- Neuro (TTP)
- Rectal bleeding (HUS)
- Stigmata of thrombocytopenia
- Petechiae
- Bleeding
- Stigmata of extravascular RBC destruction
- Systemic Symptoms
- Fever
- Night sweats
- Weight loss
- Confusion
- Other
- Trauma
- Initiation of new medication
- Recent travel
- Recent insect bites
PMH
- Hereditary spherocytosis
- Sickle cell disease
- G6PD Deficiency recently started new medication:
- Dapsone
- Phenazopyridine
- Nitrofurantoin
- Primaquine
- Rasburicase
- Methylene blue
- Tolonium chloride (toluidine blue)
- Malignancy
- Renal failure
- Connective tissue disease
- Family history of Anemia/Bleeding
Physical Exam
- Cardiovascular
- Tachycardia with flow murmur
- Heart murmur – prosthetic heart valve
- Abdominal Exam
- Hepatomegaly, splenomegaly
- Ascites
- Skin
- Petechiae
- Bruising
- Lymphadenopathy
- Brown recluse spider bites
Differential Diagnosis
Acquired Hemolytic Anemia
Microangiopathic Hemolytic Anemia
Autoimmune
Infection
Other
Hereditary/Congenital Hemolytic Anemia
- G6PD – medication induced hemolytic anemia
- Sickle cell disease
- Thalassemia
- Hereditary spherocytosis
Evaluation
Workup
- CBC
- Low hemaglobin/hematocrit
- Low platelet count → microangiopathic hemolytic anemia
- Blood smear
- Reticulocyte count
- CMP
- Most important: indirect bilirubin and creatinine
- UA (for hemoglobin, hemosiderin), uHCG
- PT/INR
- Hemolysis labs
- LDH
- Haptoglobin
- Fibrinogen
- Direct Anti-Globulin Test or Coombs test
- If concern for Malaria:
- Thick and thin prep
- Parasitemia
- HIV
- Blood cultures, urine cultures
- Consider LP if neuro symptoms
Lab Interpretation
| Microangiopathic Hemolytic Anemia | H/H | Platelets | Indirect Bili | Creatinine | Blood Smear | PT/INR | LDH | Haptoglobin | Fibrinogen | DAT/Coombs Test | Thick/Thin Prep |
| HUS | low | low | elevated | highly elevated | schistocytes | wnl | elevated | low | wnl | negative | negative |
| TTP | low | low | elevated | elevated | schistocytes | wnl | elevated | low | wnl | negative | negative |
| DIC | low | low | elevated | elevated | schistocytes | elevated | elevated | low | low | negative | negative |
| Malignant Hypertension | low | low | elevated | variable | schistocytes | elevated | low | negative | negative | ||
| Autoimmune | H/H | Platelets | Indirect Bili | Creatinine | Blood Smear | PT/INR | LDH | Haptoglobin | Fibrinogen | DAT/Coombs Test | Thick/Thin Prep |
| Warm Antibody AHA | low | wnl | elevated | spherocytes | elevated | low | wnl | positive | negative | ||
| Infection | H/H | Platelets | Indirect Bili | Creatinine | Blood Smear | PT/INR | LDH | Haptoglobin | Fibrinogen | DAT/Coombs Test | Thick/Thin Prep |
| Malaria | low | wnl | elevated | see thick/thin prep | variable | elevated | low | wnl | negative | paracytes | |
| Babesia | see thick/thin prep | negative | paracytes | ||||||||
| Other | H/H | Platelets | Indirect Bili | Creatinine | Blood Smear | PT/INR | LDH | Haptoglobin | Fibrinogen | DAT/Coombs Test | Thick/Thin Prep |
| Brown recluse | low | wnl | elevated | elevated | positive | negative |
Management
- ABC’s and resuscitation if necessary, 2 large bore IVs
- Emergent hematology consultation if patient is very ill appearing
Acquired Hemolytic Anemia
Microangiopathic Hemolytic Anemia
- HUS
- Supportive Care
- Hydration
- Pain control
- Hemodialysis if acute renal failure
- Do NOT give antibiotics: results in increased expression of Shiga Toxin from E. Coli O157:H7
- Supportive Care
- TTP
- Avoid platelet transfusion, except in life-threatening bleeding or intracranial hemorrhage
- Plasma exchange
- If Plasma exchange cannot be performed immediately, give FFP and plasmapharese later.
- Factor VIII concentrate
- DIC
- Platelet transfusion if count is <50,000 and/or significant bleeding
- pRBC if active bleeding or hemodynamically unstable
- FFP if active bleeding
- Cryoprecipitate if fibrinogen <150 and bleeding
- TXA is only indicated for active or massive bleeding
- Malignant hypertension
- Reduce blood pressure as clinically indicated
Autoimmune
- Warm antibody autoimmune hemolytic anemia
- High-dose corticosteroids PO (1-2mg/kg per day for 3-4 weeks)
- Monoclonal antibodies and immunosuppressive agents
- Plasma exchange for severe hemolysis
- Allogeneic RBC transfusion for life-threatening anemia
Infection
- Malaria
- Visit CDC website to determine resistance pattern: https://www.cdc.gov/malaria/diagnosis_treatment/treatment.html
- CDC Malaria Hotline: (770) 488-7788 or (855) 856-4713 toll-free Monday-Friday 9 am to 5 pm EST - (770) 488-7100 after hours, weekends and holidays
- Babesiosis
- Mild/moderate Disease
- Atovaquone 750mg PO q12hr AND
- Azithromycin 500mg PO on day 1, then 250mg/day PO
- Severe Disease
- Clindamycin 300-600mg IV QID OR 600mg PO TID AND
- Quinine 650mg PO TID x7-10 days
- Consider exchange transfusion if parasitemia >10%
- Supportive treatment
- Mild/moderate Disease
Other
- Brown recluse spider bite
- Supportive care
- Hemodynamic support with fluids and pressers if necessary
- Blood product transfusion if necessary
- Supportive care
Hereditary/Congenital Hemolytic Anemia
- G6PD
- Stop new medications
- Treat any infections aggressively
- Ovoid oxidant drugs
- Blood transfusion if severe illness
- Sickle Cell Disease, Thalassemia, Hereditary spherocytosis
- Hemolytic anemia in the above diseases typically chronic, usually does not require treatment in ED
Disposition
- Depends on severity, complications, etc.
